14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to control HIV-1 replication - Mercedes Bermejo; Juan Ambrosioni; Guiomar Bautista; Núria Climent; Elena Mateos; Cristina Rovira; Rafael Duarte; Francisco Cervantes; Montserrat Plana; José M. Miró; José Alcamí; Mayte Coiras (Elsevier, 2017)